IMU Biosciences
PrivateLast Round
Series A
Jun 2, 2026
Total Funding Raised
$166M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
IMU Biosciences is a biotechnology company that provides an immune discovery platform using systems-level profiling and AI to advance precision medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IMU Biosciences Comparables
Compare IMU Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Teiko Bio | 88% | |
| Immunai | 84% | |
| CytoReason | 82% |
IMU Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 2, 2026 | ||||
| Series A | Jun 2, 2026 | ||||
| Series A | Jan 24, 2024 |
Key People
Founding team and executive leadership
IMU Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LifeX Ventures | Series A, Seed |
| LifeX Ventures | Series A |
| British Business Bank | Series A |
| Meltwind Advisory | Series A |
| IQ Capital | Series A |
| Kfund | Series A |
| Molten Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 112% MoM, reaching 5.7K.
- Jul 27, 2026
Monthly visitors increased 43% MoM.
IMU Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about IMU Biosciences's valuation, stock price, and market status.
Is IMU Biosciences a public or private company?
IMU Biosciences is a private company.
What is the current stock price of IMU Biosciences?
IMU Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is IMU Biosciences worth (valuation)?
Valuation information for IMU Biosciences is not publicly available.
Can I buy IMU Biosciences stock?
IMU Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was IMU Biosciences's last funding round?
IMU Biosciences's most recent funding round was Series A on June 2, 2026.
Who are the main investors in IMU Biosciences?
Key investors in IMU Biosciences include IQ Capital, Molten Ventures, IQ Capital.
Will IMU Biosciences IPO soon?
No public IPO plans have been announced for IMU Biosciences.
How can I track IMU Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor IMU Biosciences's secondary market activity and sign up for updates.